Northern Trust
AMED

Northern Trust’s Amedisys AMED Stock Holding History

Northern Trust’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-290,933
Closed -$28.6M – 4429
2025
Q2 		$28.6M Sell
290,933
-9,734
-3% -$921K ﹤0.01% 1438
2025
Q1 		$27.9M Buy
300,667
+11,439
+4% +$1.05M ﹤0.01% 1432
2024
Q4 		$26.3M Buy
289,228
+55,264
+24% +$5.08M ﹤0.01% 1515
2024
Q3 		$22.6M Sell
233,964
-7,235
-3% -$706K ﹤0.01% 1544
2024
Q2 		$22.1M Buy
241,199
+30,803
+15% +$2.86M ﹤0.01% 1490
2024
Q1 		$19.4M Sell
210,396
-32,206
-13% -$3.02M ﹤0.01% 1618
2023
Q4 		$23.1M Sell
242,602
-3,632
-1% -$339K ﹤0.01% 1516
2023
Q3 		$23M Sell
246,234
-73,807
-23% -$6.82M ﹤0.01% 1450
2023
Q2 		$29.3M Buy
320,041
+10,334
+3% +$848K 0.01% 1329
2023
Q1 		$22.8M Sell
309,707
-289
-0.1% -$25K ﹤0.01% 1474
2022
Q4 		$25.9M Sell
309,996
-32,937
-10% -$2.97M 0.01% 1378
2022
Q3 		$33.2M Sell
342,933
-25,102
-7% -$2.99M 0.01% 1128
2022
Q2 		$38.7M Sell
368,035
-19,261
-5% -$2.46M 0.01% 1050
2022
Q1 		$66.7M Buy
387,296
+4,749
+1% +$709K 0.01% 839
2021
Q4 		$61.9M Buy
382,547
+36,972
+11% +$5.94M 0.01% 952
2021
Q3 		$51.5M Buy
345,575
+6,976
+2% +$1.45M 0.01% 1052
2021
Q2 		$82.9M Sell
338,599
-3,373
-1% -$885K 0.01% 769
2021
Q1 		$90.5M Buy
341,972
+43,363
+15% +$12.2M 0.02% 722
2020
Q4 		$87.6M Buy
298,609
+4,164
+1% +$1.07M 0.02% 701
2020
Q3 		$69.6M Sell
294,445
-9,716
-3% -$2.21M 0.02% 719
2020
Q2 		$60.4M Sell
304,161
-253,719
-45% -$47.3M 0.01% 756
2020
Q1 		$102M Buy
557,880
+2,624
+0.5% +$467K 0.03% 468
2019
Q4 		$92.7M Sell
555,256
-8,914
-2% -$1.33M 0.02% 624
2019
Q3 		$73.9M Buy
564,170
+61,310
+12% +$7.98M 0.02% 691
2019
Q2 		$61.1M Buy
502,860
+34,375
+7% +$4.08M 0.01% 858
2019
Q1 		$57.7M Buy
468,485
+87,399
+23% +$11M 0.01% 856
2018
Q4 		$44.6M Sell
381,086
-79,077
-17% -$9.32M 0.01% 947
2018
Q3 		$57.5M Sell
460,163
-30,650
-6% -$3.38M 0.01% 897
2018
Q2 		$41.9M Sell
490,813
-293,696
-37% -$21.6M 0.01% 1171
2018
Q1 		$47.3M Sell
784,509
-4,952
-0.6% -$282K 0.01% 1034
2017
Q4 		$41.6M Sell
789,461
-8,390
-1% -$442K 0.01% 1128
2017
Q3 		$44.6M Sell
797,851
-6,316
-0.8% -$334K 0.01% 1046
2017
Q2 		$50.5M Buy
804,167
+21,581
+3% +$1.26M 0.01% 921
2017
Q1 		$40M Buy
782,586
+9,179
+1% +$438K 0.01% 1097
2016
Q4 		$33M Buy
773,407
+8,341
+1% +$355K 0.01% 1213
2016
Q3 		$36.3M Buy
765,066
+8,700
+1% +$434K 0.01% 1083
2016
Q2 		$38.2M Buy
756,366
+2,113
+0.3% +$107K 0.01% 997
2016
Q1 		$36.4M Buy
754,253
+34,960
+5% +$1.35M 0.01% 1026
2015
Q4 		$28.3M Sell
719,293
-11,093
-2% -$444K 0.01% 1219
2015
Q3 		$27.7M Buy
730,386
+88,110
+14% +$3.72M 0.01% 1247
2015
Q2 		$25.5M Sell
642,276
-8,319
-1% -$259K 0.01% 1388
2015
Q1 		$17.4M Buy
650,595
+20,893
+3% +$589K 0.01% 1685
2014
Q4 		$18.5M Sell
629,702
-2,860
-0.5% -$70.6K 0.01% 1600
2014
Q3 		$12.8M Sell
632,562
-29,066
-4% -$561K ﹤0.01% 1855
2014
Q2 		$11.1M Sell
661,628
-42,904
-6% -$608K ﹤0.01% 1968
2014
Q1 		$10.5M Sell
704,532
-31,573
-4% -$486K ﹤0.01% 2067
2013
Q4 		$10.8M Buy
736,105
+18,761
+3% +$302K ﹤0.01% 2042
2013
Q3 		$12.3M Buy
717,344
+1,785
+0.2% +$26.5K ﹤0.01% 1864
2013
Q2 		$8.3M Buy
+715,559
New +$8.2M ﹤0.01% 2052

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Northern Trust's AMED Position: Q3 2025 in Review

Northern Trust sold out of Amedisys (AMED) in Q3 2025, closing a stake of 290,933 shares — an estimated $28.6M sold.

Northern Trust first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $102M in Q1 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Northern Trust reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Northern Trust sold 290,933 Amedisys shares in Q3 2025, an estimated $28.6M.
  • Northern Trust first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Northern Trust's Amedisys position peaked at $102M in Q1 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Northern Trust's 13F filing for Q3 2025, filed 14 Nov 2025.